REVIEW
|
doi:10.20944/preprints202206.0286.v1
Subject:
Medicine And Pharmacology,
Urology And Nephrology
Keywords:
interleukin-17; renal cell carcinoma; immunotherapy; inflammation; tumor microenviroment; tumor development; Th17 lymphocytes
Online: 21 June 2022 (05:11:36 CEST)